Fox Business - The Power to Prosper
Search Site


AVEO

  • Last Update

  • Change

  • Volume / Avg.

  • Prev. Close

Today's Performance

52-Week Range

AVEO Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA.